Targeted CRISPR-Cas9 screening identifies core transcription factors controlling murine haemato-endothelial fate commitment

Journal:

Nature Communications

Published:

2025-12-13

DOI:

10.1038/s41467-025-66230-9

Affiliations:

11

Authors:

13

Go to article

Institutions	Authors	Share
University of Zurich (UZH), Switzerland	9.166667	0.71
Institute of Molecular Biotechnology (IMBA), Austria	1.000000	0.08
EMBL - Rome, Italy	1.000000	0.08
Rede de Química e Tecnologia (REQUIMTE), Portugal	0.500000	0.04
Institute for Health and Bioeconomy (i4HB), Portugal	0.500000	0.04
Utrecht University (UU), Netherlands	0.500000	0.04
Catholic University of Portugal (UCP), Portugal	0.333333	0.03

Interested in Medical Biotechnology?